PL1984014T3 - Zastosowanie peptydowych związków TPO i kompozycji farmaceutycznych w leczeniu niedokrwistości - Google Patents

Zastosowanie peptydowych związków TPO i kompozycji farmaceutycznych w leczeniu niedokrwistości

Info

Publication number
PL1984014T3
PL1984014T3 PL06735131T PL06735131T PL1984014T3 PL 1984014 T3 PL1984014 T3 PL 1984014T3 PL 06735131 T PL06735131 T PL 06735131T PL 06735131 T PL06735131 T PL 06735131T PL 1984014 T3 PL1984014 T3 PL 1984014T3
Authority
PL
Poland
Prior art keywords
anemia
treatment
pharmaceutical compositions
peptide compounds
tpo peptide
Prior art date
Application number
PL06735131T
Other languages
English (en)
Inventor
Edward J Yurkow
Brian R Macdonald
Jeffery K Weis
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PL1984014T3 publication Critical patent/PL1984014T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/524Thrombopoietin, i.e. C-MPL ligand
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/196Thrombopoietin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL06735131T 2006-02-14 2006-02-14 Zastosowanie peptydowych związków TPO i kompozycji farmaceutycznych w leczeniu niedokrwistości PL1984014T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06735131.2A EP1984014B1 (en) 2006-02-14 2006-02-14 Use of tpo peptide compounds and pharmaceutical compositions in the treatment of anemia
PCT/US2006/005322 WO2007094781A1 (en) 2006-02-14 2006-02-14 Use of tpo peptide compounds and pharmaceutical compositions in the treatment of anemia

Publications (1)

Publication Number Publication Date
PL1984014T3 true PL1984014T3 (pl) 2015-02-27

Family

ID=37904365

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06735131T PL1984014T3 (pl) 2006-02-14 2006-02-14 Zastosowanie peptydowych związków TPO i kompozycji farmaceutycznych w leczeniu niedokrwistości

Country Status (19)

Country Link
EP (1) EP1984014B1 (pl)
JP (1) JP2009526841A (pl)
CN (1) CN101374540B (pl)
AU (1) AU2006338308B2 (pl)
BR (1) BRPI0621347B8 (pl)
CA (1) CA2642389C (pl)
CY (1) CY1115629T1 (pl)
DK (1) DK1984014T3 (pl)
EA (1) EA015562B1 (pl)
ES (1) ES2516649T3 (pl)
HK (2) HK1125055A1 (pl)
IL (1) IL193268A (pl)
NI (1) NI200800216A (pl)
NO (1) NO341872B1 (pl)
NZ (1) NZ570124A (pl)
PL (1) PL1984014T3 (pl)
PT (1) PT1984014E (pl)
SI (1) SI1984014T1 (pl)
WO (1) WO2007094781A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2726603A1 (en) * 2008-06-03 2009-12-10 Janssen Pharmaceutica Nv Dosing regimen
JP6150374B2 (ja) * 2012-11-15 2017-06-21 国立大学法人弘前大学 放射線被ばく治療剤及び放射線被ばく治療方法
KR20200059213A (ko) 2017-07-26 2020-05-28 잔센파마슈티카엔.브이. 표적화된 방사선 치료요법에 의해 유도된 혈관 무결성을 보호하는 방법
KR20210120037A (ko) 2019-01-25 2021-10-06 잔센파마슈티카엔.브이. 수포제 및 가성 가스의 독성 영향 경감 방법
MA54821A (fr) 2019-01-25 2021-12-01 Janssen Pharmaceutica Nv Méthodes pour augmenter la protection contre les lésions des organes et des vaisseaux, la récupération hématopoïétique et la survie en réponse à une exposition à une irradiation corporelle totale ou à des agents chimiques
EP3914272B1 (en) 2019-01-25 2024-03-06 Janssen Pharmaceutica NV Thrombopoietin mimetics for mitigating liver injury and promoting liver hypertrophy, regeneration and cell engraftment in conjunction with radiation and/or radiomimetic treatments
IL311797A (en) 2021-10-01 2024-05-01 Albert Einstein College Of Medicine Methods for increasing stem cell production
WO2024095178A1 (en) 2022-11-01 2024-05-10 Janssen Pharmaceutica Nv Thrombopoietin mimetic for use in the treatment of acute liver failure

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995021626A1 (en) * 1994-02-14 1995-08-17 University Of Washington Methods for stimulating erythropoiesis using thrombopoietin
KR20050093759A (ko) * 2002-09-18 2005-09-23 오르토-맥네일 파마슈티칼, 인코퍼레이티드 혈소판 및 조혈 줄기세포의 생산을 증가시키는 방법
JP4848277B2 (ja) * 2003-08-28 2011-12-28 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 受容体に結合するペプチドおよび化合物

Also Published As

Publication number Publication date
AU2006338308B2 (en) 2012-11-01
CN101374540A (zh) 2009-02-25
BRPI0621347A2 (pt) 2011-12-06
BRPI0621347B8 (pt) 2021-05-25
CA2642389A1 (en) 2007-08-23
SI1984014T1 (sl) 2014-12-31
NZ570124A (en) 2011-05-27
AU2006338308A1 (en) 2007-08-23
PT1984014E (pt) 2014-11-13
CA2642389C (en) 2014-05-06
EP1984014A1 (en) 2008-10-29
EP1984014B1 (en) 2014-08-06
IL193268A0 (en) 2009-02-11
JP2009526841A (ja) 2009-07-23
HK1125055A1 (en) 2009-07-31
NI200800216A (es) 2012-01-24
EA015562B1 (ru) 2011-08-30
EA200870261A1 (ru) 2009-02-27
HK1129571A1 (en) 2009-12-04
IL193268A (en) 2015-02-26
WO2007094781A1 (en) 2007-08-23
NO20083928L (no) 2008-09-15
CN101374540B (zh) 2013-03-06
BRPI0621347B1 (pt) 2018-05-08
DK1984014T3 (da) 2014-09-15
NO341872B1 (no) 2018-02-12
ES2516649T3 (es) 2014-10-31
CY1115629T1 (el) 2017-01-04

Similar Documents

Publication Publication Date Title
IL185462A0 (en) New pharmaceutical compositions useful in the treatment of pain
HK1221252A1 (zh) 限制的 肽及含有其的藥物組合物
IL197275A0 (en) Pharmaceutical compositions of clonazepam and methods of use thereof
IL195947A (en) Manicured cyclic compounds and pharmaceutical preparations containing them for use @ for prevention @ and treatment @ for diabetes
IL222879A (en) Peptides and their use in the treatment and diagnosis of diseases and pharmaceutical preparations containing them
EP1773369A4 (en) PHARMACEUTICAL COMPOSITIONS AND METHOD FOR THE PEPTIDE TREATMENT
EP2056835A4 (en) PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
HK1125055A1 (en) Use of tpo peptide compounds and pharmaceutical compositions in the treatment of anemia tpo
IL194429A0 (en) Camptothecin-cell penetrating peptide conjugates and pharmaceutical compositions containing the same
PL2601961T3 (pl) Kompozycje zawierające LAG-3 i terapeutyczne przeciwciała oraz ich zastosowania w leczeniu raka
EP1890677A4 (en) PHARMACEUTICAL COMPOSITIONS AND THEIR USE
IL196033A0 (en) Pyrrolotriazine derivatives and pharmaceutical compositions containing the same
IL186959A0 (en) Peptides and pharmaceutical compositions containing the same
HK1244819A1 (zh) Foxm1肽和包含foxm1肽的藥劑
EP2079526A4 (en) COMPOSITIONS AND ITS USES IN THE TREATMENT OF WOUNDS
HK1141312A1 (en) Cdca1 peptide and pharmaceutical agent comprising the same cdca1
IL178067A0 (en) Pharmaceutical dosage forms and compositions
PL2066408T3 (pl) Kompozycja na bazie ksantoksyliny i jej zastosowanie w kosmetyce
PL2012805T3 (pl) Kompozycja lecznicza i jej zastosowanie
HK1111599A1 (en) Pharmaceutical compositions for the treatment of cellulite
GB0614365D0 (en) Pharmaceutical compositions and their use
EP1937292A4 (en) LOPAP-BASED PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
IL189827A0 (en) Pharmaceutical dosage forms and compositions comprising lecoztan
ZA200609585B (en) Compositions comprising glycosaminoglycan and non steriodal anti-inflammatory drug
ZA200807876B (en) Use of TPO peptide compounds and pharmaceutical compositions in the treatment of anemia